Positive day sunny hydrogen sulphate pipropogram tablets approved in the immediate

Pharmaceutical Network June 18 , recently , Nanjing Zhengda Qing's sulphate clopidogrel tablets ( accepting the number CYHS1800273) imitation 4 categories of listing applications into the administrative approval stage , is expected to be approved for listing in the near futureAccording to The Data of Minne Net, sales of chlorpyrifos at the terminal of China's public medical institutions in 2019 were RMB11,572 million, and the application for listing of hydrogen pyrosulhonograml tablets from nine pharmaceutical companies, such as Dongsun Pharmaceuticals and Yangzijiang, was in the reviewHydrosulphate clopidogrel tablets are antithrombotic drugs and have been included in the first batch ofAccording to The Net data show that in 2017, china's urban publichospitals
county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal choverpiedre sales exceeded 10 billion yuan, sales reached a peak of 12.2 billion yuan in 2018, affected by the "4 plus 7" collection price reduction, 2019 sales of hydrogen chloride pistrays fell to 11.572 billion yuan, down 5.45 percent year-on-yearChina's public medical institutions terminal clopidogrel sales (units: 10,000 yuan)the current domestic market has 6 enterprises have sulphate clopidogrel tablet production approval, respectively, Sanofi, Lideska, Lepu Pharmaceuticals, Stone Pharmaceuticals Oyi, Atvis, DrReddy India laboratoryIn terms of corporate competitivelandscape, china's public medical institutionterminal Clopidogree market leader in 2019 is still Sanofi, accounting for 57.45 percent of the market share, and Xinlita accounted for 28.99 percentIn 2019, China's public medical institutions terminal clopidogrel competition pattern"4 plus 7" collection, sulphate clopidogrel tablets by The independent bid, "4 plus 7" expansion, sulphate clopidogreree tablet market by Sanofi, stone drug Oege, Le Pharmaceuticals three melonsAlthough clopidogrel has been included in the collection, Nanjing Zhengda Qing and other domestic pharmaceutical companies are still actively layoutMinnet data show that Yangzijiang Pharmaceutical Group, East Sunshine Medicine, Yuandong Biological ..Nineenterprisessubmitted for listing of biophosulphate pipropnorel tablets under the imitation category 4 　　Applications for listing of hydrosulphate clopidogrel tablets are in the review enterprise Source: CDE Official Website, Minnet Database